Raymond H. Cypess, DVM, PhD
Raymond is Chairman and CEO of ATCC and ATCC Global. In this role, he has demonstrated the ability to apply business acumen, fiscal responsibility and innovative approaches to the management of a non-profit/profit corporate structure. He holds a DVM from the University of Illinois and a PhD in parasitology from the University of North Carolina.
Prior to joining ATCC, Raymond was Dean of the College of Graduate Health Sciences, Professor of Microbiology and Immunology and Comparative Medicine, and Vice Provost for Research and Research Training, at the University of Tennessee, Memphis. He was awarded the University of Tennessee Memphis College of Medicine Outstanding Teacher Award for 1989–1993. Raymond has been an Associate Professor of Epidemiology and Microbiology at the University of Pittsburgh School of Public Health and Professor and Chairman at the New York State College of Veterinary Medicine.
Raymond participated on National Institute of Allergy and Infectious Disease (NIAID) scientific review boards and various NIH Study Sections and served on several editorial boards. He is the author of more than 80 chapters, reviews, and journal articles, a fellow in the Infectious Disease Society, and a member of the American Epidemiology Society. At ATCC, he has served as principal investigator on numerous grants and contracts, including the Malaria Research & Reference Reagent Resource Center (MR4) and the Biodefense & Emerging Infectious Research Resources Repository (BEI) from NIAID. He has served on boards of the New York Stock Exchange and NASDAQ corporations as well as Director and Treasurer of the Virginia Biotechnology Authority.
Mindy Goldsborough, PhD
ATCC Cell Systems
Mindy oversees the ATCC Cell Systems (ACS) business unit which is located in Gaithersburg, MD. ACS was recently formed within the ATCC organization as an innovative product and technology development arm of ATCC. Its current focus is in areas of functional cell biology supporting basic and translational research. ACS is located in the Maryland High Technology Corridor to enable the site to be an active participant in the area’s well established biotechnology community.
Prior to joining ATCC, Mindy was with BD Biosciences as the Director of R&D in the Advanced Bioprocessing group of BD. Prior to that role, she held several positions of increasing responsibility within the BD Biosciences Bioimaging business (formerly Atto Biosciences), including Director of R&D. Prior to BD, she was at Life Technologies where Mindy lead efforts in several diverse areas including DNA-based diagnostics, stem cell biology, forensics and nucleic acid purification. Mindy brings over 25 years of product and technology development expertise in cell and molecular biology to ATCC; several products that Mindy helped develop during her career are still market standards today. She earned her Ph.D. in Genetics from The George Washington University and did her dissertation research and post-doctoral work at The National Institutes of Health, National Cancer Institute.
Leonard P. Freedman, PhD
Chief Scientific Officer/President, GBSI
Leonard P. Freedman, Ph.D. is Chief Scientific Officer, ATCC, and founding President of the Global Biological Standards Institute (GBSI) in Washington, DC. He has over 30 years of research, management, and program development experience in molecular and cell biology, biomedical research, and drug discovery for both the private sector and academia. Dr. Freedman is a recognized leader in the field of nuclear hormone receptors. Prior to joining the GBSI, Dr. Freedman was Vice Dean for Research and a Professor of Biochemistry and Molecular Biology at Jefferson Medical College, Thomas Jefferson University, in Philadelphia, Pennsylvania. As Vice Dean, Dr. Freedman developed a coordinated strategy to drive the effective integration of the medical college’s clinical/educational expertise with the university’s basic and clinical research programs and activities. He also developed strategic alliances with multiple universities, medical centers, and other research organizations. Previously, Dr. Freedman served as Vice President of Discovery for Women’s Health and Musculoskeletal Therapies at Wyeth Research, and was the Executive Director for the Department of Molecular Endocrinology at Merck Research Labs. After obtaining his Ph.D., Dr. Freedman joined the faculty in Cell Biology & Genetics at Memorial Sloan-Kettering Cancer Center and the Cornell University Medical College where he rose to tenured Full Professor. He is a member of several professional societies, has published extensively, and served on numerous scientific review panels.
Dr. Freedman has a B.A. in Biology from Kalamazoo College, and an M.S. and Ph.D. in Molecular Genetics from the University of Rochester. He was a member of the Board of Directors of ATCC and the BioNexus Foundation from 2010-12.
Drew Cawthon, PhD
Senior Director, Government Contracts
Drew oversees the management of ATCC’s multiple government contracts. These contracts cover the areas of infectious disease, cancer and toxins, and serve to provide quality controlled standardized biological reagents, assays, and services to support investigators in basic and applied research with the goal of providing consistent results among laboratories. Drew also oversees the CORES laboratories which support technology development across ATCC’s three business units.
Prior to joining ATCC, Drew served as the Director of Preclinical Microbiology and Immunotoxicology at Lovelace Respiratory Research Institute, where he managed a biocontainment facility and the scientific and technical staff that supported preclinical evaluation of vaccines and therapeutics targeting biodefense pathogens, toxins, and emerging infectious diseases. He received his PhD in Microbiology and Immunology from Wake Forest University School of Medicine.
Matthew Klusas, MS
Senior Director of Corporate Development
Matthew oversees business development, strategic partnerships, intellectual property, licensing, and international distributor relationships for ATCC .
Prior to joining ATCC, Matthew worked at Life Technologies as an integration leader and Chief of Staff for the Genetic Systems Division. He held roles at McKinsey & Co., Deutsche Bank, the Chicago Board of Trade, and the Federal Reserve Bank of Chicago. Matthew has been published in the McKinsey Quarterly and the Credit Union Journal. He received a BS from the Illinois State University and a MSc from the London School of Economics.
Bill Folkerts, MBA
Vice President, Sales and Marketing
Bill brings to ATCC experience in multiple disciplines including international marketing, business development, strategic sales, government contracting, program management, quality management, and scientific research. Throughout his 30 year career, Bill has held roles of increasing responsibility in several key global biotechnology firms and recognized academic institutions including Johns Hopkins University, Chesapeake Biological Laboratories, Becton Dickinson (BD), Life Technologies (Invitrogen), QIAGEN and Lonza.
Bill has experience in the following market segments: Life Science Research, Clinical Diagnostics, Pharmaceuticals / Biologics, Government Contracting and Applied Markets – Forensics, Food, Veterinary Diagnostics, Biodefense. His board experience includes Maryland Chamber of Commerce, AOAC Stakeholders Panel on Agent Detection Assays, Susceptibility Testing Manufacturers Association and Clinical Laboratory Standards Institute.
Bill is a graduate of Towson University and the University of Baltimore (part of the University System of Maryland) and holds a BS in Biology / Chemistry and a Masters in Business Administration.
Teri Sellars, SPHR
Senior Director, Human Resources
Teri oversees all Human Capital activities for ATCC.
Before joining ATCC, Teri was Director, Human Resources, for Analytic Services Inc., a not-for-profit corporation which provides expertise to public sector clients in the arenas of national and homeland security. Prior to Analytic Services Inc., Teri led the Human Resources function as a Director and Human Resources Business Partner for small companies and for divisions of larger organizations, including Convergys Corporation, Freddie Mac, Wireless Facilities, Inc., and WCI Communities.
Teri received her Bachelor’s Degree in French Business Studies from the University of Illinois at Chicago and completed a year of study at the University of Paris - La Sorbonne in Paris, France. Teri is a member of the National Society for Human Resources, as well as the Dulles SHRM and Northern SHRM chapters, and has served on the Board of the Dulles SHRM chapter.
Senior Director, Compliance & Regulatory Affairs/CCO
Kristina oversees Compliance, Quality Assurance, Safety, and Security programs for ATCC.
Prior to joining ATCC in 1998, Kristina worked for a small bio-tech company in the development of investigational and in-vitro diagnostic test kits for the rapid identification of pathogens in poultry and the identification of emerging infectious diseases. Prior to joining the medical device manufacture, Kristina worked for the poultry industry developing and implementing Hazard Analysis Critical Control Point and Total Quality Management programs in collaboration with the United States Department of Agriculture for the production and distribution of finished poultry products. Kristina is a graduate of Virginia Tech with a Bachelor’s Degree in Biology and a study emphasis in Microbiology.
George Vaseghi, MS
Senior Director, Information Technology
George oversees information technology for ATCC, aligning technology policy, solutions, and operations with current and future business requirements.
Prior to this position, George was the Director of Business Systems for ATCC, managing all application systems supporting manufacturing, cold supply chain operations, contract services, SG&A, and R&D. Before joining ATCC, George was an Operations Research Analyst with the United States Marine Corps. He received a BS in Agricultural Engineering from Cornell University and a MS in Operations Research from the Naval Postgraduate School.
Miguel Carrión, MS
Miguel oversees the management of ATCC’s manufacturing and supply chain activities in support of the production, preservation, inventory control and distribution of a wide range of biological materials for life science research, including cell lines, microorganisms, molecular genomics tools and other ancillary bioproducts.
Prior to joining ATCC, Miguel was part of Lonza Biosciences’ Custom Manufacturing division and served as a Senior Manager of Process Development for the Cell Therapy Business Unit. Prior to that role he consulted for Principio Inc. as a Senior Director of Research. Miguel also worked at GenVec as an Associate Director of Biochemistry, overseeing the development of novel viral vector-based therapies and vaccines, and as a Protein Chemist at the Medical Research division of American Cyanamid (now Pfizer) Lederle Laboratories. Miguel is an inventor on multiple issued US and EU patents. He received an MS in Chemistry and a BS in Zoology from Eastern Illinois University.